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(5-20 mM) were added to the cell cultures before and during the OGD/R
phases to investigate the underlying mechanism.
RESULTS Our data showed that OGD/R decreased cell viability,
increased lactate dehydrogenase leakage, reactive oxygen species and
malondialdehydeproduction inH9c2 cells, all ofwhichwere signiﬁcantly
reversed by propofol. Moreover, we found that propofol increased both
the activities and protein expressions of superoxide dismutase and
catalase. In addition, propofol increased FoxO1 expression in a dose-
dependent manner and inhibited p-AMPK formation signiﬁcantly.
CONCLUSIONS These results indicate that the propofol might exert its
antioxidative effect through FoxO1 in H9c2 cells, and it has a potential
therapeutic effect on cardiac disorders involved in oxidative stress.
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OBJECTIVES Currently surgical myectomy and ethanol ablation are two
established interventions for relieving the left ventricular outﬂow
obstruction in hypertrophic cardiomyopathy (HCM) patients. The limi-
tations in safety and efﬁcacy in these interventions call for minimally
invasive, potentially safer andmore efﬁcacious approach. The aim of this
study is to validate the feasibility of echocardiography-guided percuta-
neous per-ventricular laser ablation of the canine ventricular septum.
METHODS Six domestic dogs were chosen for the study. Laser (Nd:
YAG, 800-1064 nm-wavelength, 300mm-diameter ﬁber, Echo Laser
X4, Elesta S.R.L., Italy) was used. The laser passed through a needle
(21G, PTC, ECOCHIBA, Italy) that inserted from the right ventricle into
the targeted septum under the guidance of the echocardiography via a
percutaneous route. Laser ablation was performed as follows: 1 W
laser for 3 and 5 min at 180 and 300 J, respectively. Echocardiography,
serology examination and pathology were performed to assess the
results of laser ablation.
RESULTS There was no death or major complication, i.e. tamponade,
pericardial effusion or ventricular ﬁbrillation. The real-time echocar-
diography monitor of M-mode, 2D (LVEF), PW Doppler and TDI pre-
sented no signiﬁcant variation before and after the laser ablation.
Contrast echocardiography conﬁrmed the perfusion defects in the
ablated septal regions. The laser ablated areas were well demarcated
on pathology examination and the diameters of the ablated region
were (mm) 4.42  0.57 and 5.28  0.83 for 3- and 5-minute ablation,
respectively. Pre- and post-ablation cardiac enzymes (IU/L) were: AST:
39.17  11.23 vs 183  101.07 (p¼0.02), LDH: 71  33.89 vs 253.33 
179.63 (p¼0.07), CK: 468.17 192.42 vs 2775.17  1309.35 (p¼0.007),
and CK-MB: 174.33  113.34 vs 897.17  486.84 (p¼0.03). Microscop-
ically, the ablated myocardium showed contracted coagulative
changes. Nuclei disappeared and a zone of vacuoles was formed with
red blood cells inﬁltrating into the widened intercellular space.
CONCLUSIONS Our research showed that percutaneous laser ablation
of the septum is feasible, potentially safe and efﬁcacious and may
become a viable alternative solution to septum ablation.
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OBJECTIVES The aims of this study were to determine whether Myr
or DMY exert any cardioprotective effect against I/R injury and
investigate the responsible underlying mechanisms.
METHODS The study utilized an in vitro rat cardiomyocyteH9C2model
of hypoxia/reoxygenation (H/R) injury and an in vivo rat model of MI/R
injury. H/R injury was determined by Cell Counting Kit-8 (CCK-8) assay
and lactate dehydrogenase (LDH) leakage assay. In the in vivoexperiment, histopathology staining was examined. Additionally, car-
diac injury markers maleic dialdehyde (MDA), superoxide dismutase
(SOD), glutathione reductase (GSH), myeloperoxidase (MPO), nitric-
oxide synthase (NOS), Ca2þ-Mg2þ-ATPase and Naþ-Kþ-ATPase were
detected. TUNEL assay and caspases activation assays were used to
investigate apoptosis. To assess levels of apoptotic regulators, immu-
nohistochemical staining and real-time PCR were employed.
RESULTS Both Myr and DMY have no cytotoxic effect at the concen-
trations of 0.5-80 mMMyr or 10-200 mMDMY for 24 hours in H9C2 cells.
after being subject to H/R, cellular viability was signiﬁcantly reduced in
the H/R group (P < 0.01 compared to control), and LDH leakage was
highly increased compared to control (P < 0.01). DMY or Myr post-
conditioning signiﬁcantly increased cell viability compared with the H/
R group. DMY (25, 50 and 100 mM) or Myr (20 and 50 mM) markedly
reducedH/R-induced cell death and decreased LDH leakage (P<0.05 or
P < 0.01). These results indicate that DMY and Myr signiﬁcantly pre-
served cellular viability post-H/R injury in a dose-dependent manner.
Both DMY andMyr protectedmyocardium against I/R (or H/R) injury by
increasing NOS, SOD, GSH and ATPases activity, decreasing MDA con-
tent and MPO activity at different degrees and attenuating histopa-
thology injury. Meanwhile, DMY and Myr inhibited the cardiomyocyte
apoptosis. The level of Bcl-2 protein and mRNA were restored to the
normal level by DMY or Myr pharmacological postconditioning. In
contrast, the Bax protein level andmRNA level were markedly reduced
by DMY and Myr pharmacological postconditioning.
CONCLUSIONS DMY andMyr pharmacological postconditioning could
protect againstmyocardial I/R injury in both in vivo and in vitromodels,
which are related to apoptosis pathway and antioxidant activity.
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OBJECTIVES To observe the effect of high glucose on the protein
expression of calreticulin (CRT) and its association with cell apoptosis
and mitochondrial dysfunction in the cardiomyocytes.
METHODS AC-16 cardiomyocytes were randomly divided into normal
glucose group, high glucose group, high glucoseþ CRT siRNA and
isotonic control group. The cell apoptotic rate, reactive oxygen species
(ROS), mitochondrial membrane potential level, respiratory enzyme
activities, and protein expression of CRT were observed.
RESULTS Compared with the cardiomyocytes in normal glucose
group, the apoptotic rate of cardiomyocytes and ROS production
increased in high glucose groups, accompanying with the decreases in
the mitochondrial membrane potential level and enzyme activities of
the respiratory chain. The protein expression of CRT was signiﬁcantly
increased in high glucose group. However, compared with high
glucose group, high glucoseþ CRT siRNA decreased the expression of
CRT and attenuated the damage of mitochondrion, but CRT siRNA did
not reduce the ROS level in cardiomyocytes.
CONCLUSIONS High glucose brought about CRT over-expression to
induce mitochondrial injury, which may be a reason of increasing
myocardial apoptosis.
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OBJECTIVES L-carnitine is indispensable for energy metabolism and
mitochondrial function in the myocardium. Although carnitine
